ABIOMED
Abiomed is a provider of mechanical circulatory support devices and offers a continuum of care to heart failure patients. The Company develops, manufacture and market products that is designed to enable the heart to rest, heal and recover by improving blood flow and/or performing the pumping function of the heart. The Company's products are used in the cardiac catheterization lab (cath lab) by interventional cardiologists and in the heart surgery suite by heart surgeons for patients who are in need of hemodynamic support prophylactically or emergently before, during or after angioplasty or heart surgery procedures.
ABIOMED
Industry:
Health Care Medical Medical Device
Founded:
1981-01-01
Address:
Danvers, Massachusetts, United States
Country:
United States
Website Url:
http://www.abiomed.com
Total Employee:
501+
Status:
Active
Contact:
(978) 646-1400
Email Addresses:
[email protected].
Total Funding:
0
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Font API LetsEncrypt Apple Mobile Web Clips Icon Google Tag Manager Content Delivery Network Domain Not Resolving
Current Advisors List
Current Employees Featured
Founder
Stock Details
Acquisitions List
| Date | Company | Article | Price |
|---|---|---|---|
| 2021-06-01 | preCARDIA | preCARDIA acquired by Abiomed | N/A |
| 2020-04-29 | Breethe | Breethe acquired by Abiomed | N/A |
| 2014-07-01 | ECP Entwicklungsgesellschaft | ECP Entwicklungsgesellschaft acquired by Abiomed | 13 M USD |
| 2005-04-28 | Impella Cardiosystems | Impella Cardiosystems acquired by Abiomed | N/A |
Investors List
EW Healthcare Partners
EW Healthcare Partners investment in Post-IPO Equity - Abiomed
Investments List
| Date | Company | Article | Money raised |
|---|---|---|---|
| 2022-05-12 | Impulse Dynamics | Abiomed investment in Venture Round - Impulse Dynamics | 101 M USD |
| 2019-12-03 | Impulse Dynamics | Abiomed investment in Series D - Impulse Dynamics | 80.25 M USD |
| 2018-12-06 | Shockwave Medical | Abiomed investment in Series D - Shockwave Medical | 15 M USD |
| 2018-09-13 | RenalGuard Solutions | Abiomed investment in Series B - RenalGuard Solutions | 7 M USD |
| 2018-09-13 | Protembis | Abiomed investment in Series A - Protembis | 10 M USD |
| 2018-09-12 | Reprieve Cardiovascular | Abiomed investment in Venture Round - Reprieve Cardiovascular | 7 M USD |
| 2017-09-28 | Magenta Medical | Abiomed investment in Series B - Magenta Medical | 15 M USD |
| 2017-04-11 | ALung Technologies | Abiomed investment in Series C - ALung Technologies | 36 M USD |
Key Employee Changes
| Date | New article |
|---|---|
| 2020-06-15 | Abiomed appoints new chief medical officer |
Official Site Inspections
http://www.abiomed.com Semrush global rank: 343.51 K Semrush visits lastest month: 174.31 K
- Host name: 104.16.213.111
- IP address: 104.16.213.111
- Location: United States
- Latitude: 37.751
- Longitude: -97.822
- Timezone: America/Chicago
More informations about "Abiomed"
Home | Abiomed.com
Abiomed Breethe OXY-1 System™ The OXY-1 System is an easy-to-use, compact cardiopulmonary support system, with an integrated oxygen concentrator that provides an independent oxygen source designed to support …See details»
Abiomed - Wikipedia
Abiomed, Inc. is a medical device technology company that operates as a stand-alone business within Johnson & Johnson's MedTech Segment. Abiomed develops and manufactures temporary external and implantable mechanical circulatory support devices. The company is headquartered in Danvers, Massachusetts with additional offices in Woburn, Baltimore, Berlin, Aachen, and See details»
Johnson & Johnson Completes Acquisition of Abiomed
Dec 22, 2022 Abiomed shareholders will also receive a non-tradeable contingent value right (“CVR”) entitling the holder to receive up to $35.00 per share in cash if certain commercial and clinical milestones are achieved. …See details»
Abiomed® - Leading in Heart and Lung Recovery
Abiomed is a leading provider of groundbreaking medical technology that provides circulatory and oxygenation support. The Impella® heart pump platform is designed to enable the heart to rest and recover by improving blood flow …See details»
Org Chart Abiomed - The Official Board
The organizational chart of Abiomed displays its 13 main executives including Andrew Greenfield, Todd Tetreault and Will Danzinger. Toggle navigation The Official Board. Search. Search. Search by segment. ... you don't own enough …See details»
Johnson & Johnson Completes Acquisition of Abiomed
Dec 22, 2022 NEW BRUNSWICK, N.J. – December 22, 2022 – Johnson & Johnson (NYSE: JNJ), the world’s largest, most diversified healthcare products company, today announced it …See details»
Abiomed - Crunchbase Company Profile & Funding
Abiomed is a provider of mechanical circulatory support devices and offers a continuum of care to heart failure patients. The Company develops, manufacture and market products that is …See details»
Abiomed - Crunchbase Company Profile & Funding
Abiomed is a provider of mechanical circulatory support devices and offers a continuum of care to heart failure patients. Search Crunchbase. Start Free Trial . Chrome Extension. Solutions. …See details»
Abiomed, Inc. - AnnualReports.com
Abiomed (NASDAQ: ABMD) is a pioneer and global leader in healthcare technology and innovation, with a mission of RECOVERING HEARTS AND SAVING LIVES. Abiomed CEO, Chairman, and President, Michael R. …See details»
Abiomed - The Org
Abiomed is a pioneer and global leader in healthcare technology and innovation, with a mission of recovering hearts and saving lives.See details»
Abiomed® Executive Team
Portraits of the members of Abiomed's executive team Andrew J. Greenfield Worldwide President. Nonna Akopyan General Counsel. Adrienne Carney Global Head of Human Resources, Abiomed . Will Danzinger Chief Operating Officer. …See details»
ABIOMED - businessabc
Nov 15, 2024 In May 2018, Abiomed was added to the S&P 500 index. During the S&P's rise from 2000 to 3000, Abiomed was the index's top-performing stock. In 2018, Abiomed built a …See details»
Abiomed - Funding, Financials, Valuation & Investors - Crunchbase
Dec 29, 2011 Abiomed has raised 1 round. This was a Post-IPO Equity round raised on Dec 29, 2011. Abiomed is registered under the ticker NASDAQ:ABMD . Abiomed is funded by Essex …See details»
How Abiomed redefines heart patient care - Microsoft in Business …
Jan 15, 2019 It began in 1981 with a muse, a big idea, and a broken heart. Having lost his father to a massive and unexpected heart attack the year prior, David Lederman resolved to develop …See details»
Abiomed - Quality Assurance and Compliance - The Org
The Quality Assurance and Compliance team at Abiomed ensures that all products and processes meet stringent regulatory standards and quality expectations. This team is responsible for …See details»
About Us - Abiomed
Abiomed is a leading provider of groundbreaking medical technology that provides circulatory and oxygenation support. The Impella® heart pump platform is designed to enable the heart to rest …See details»
ABIOMED - Overview, News & Similar companies | ZoomInfo.com
Abiomed Inc (Abiomed) is a medical device company that develops, manufactures, and markets circulatory support devices. The... Jan 16, 2024. www.prnewswire.com . Read more news. …See details»
Abiomed - Internal Calendar Landing Page Only
This page is restricted for Abiomed’s internal use only. Please click the button below to log in via SSO.See details»
Our Story | Abiomed.com
Abiomed was founded in 1981 for the purpose of developing the world's first artificial heart. This interactive timeline shows how Abiomed’s mission evolved to focus on native heart recovery. …See details»
Use of Cervical Approach for Insertion of the Impella 5.5 …
4 days ago Impella 5.5 ventricular assist device (VAD) insertion is typically done via the axillary artery or directly through the aorta; however, an axillary artery must be ≥6 mm in diameter, …See details»